China Nuclear Medicine/Radiopharmaceuticals Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Nuclear Medicine/Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Nuclear Medicine/Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine/Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Dongcheng

    • Advanced Molecular-imaging Solution

    • Shanghai Atom Kexing

    • China Isotope & Radiation

    • Ciaeriar

    • Jaco

    By Type:

    • Diagnostic

    • Therapeutic

    By End-User:

    • Oncology

    • Thyroid

    • Cardiology

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine/Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Diagnostic from 2016 to 2027

    • 1.3.2 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2016 to 2027

    • 1.4.2 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2016 to 2027

    • 1.4.3 China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Nuclear Medicine/Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine/Radiopharmaceuticals by Major Types

    • 3.4.1 Market Size and Growth Rate of Diagnostic

    • 3.4.2 Market Size and Growth Rate of Therapeutic

    4 Segmentation of Nuclear Medicine/Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine/Radiopharmaceuticals by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals in Oncology

    • 4.4.2 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals in Thyroid

    • 4.4.3 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals in Cardiology

    5 Market Analysis by Regions

    • 5.1 China Nuclear Medicine/Radiopharmaceuticals Production Analysis by Regions

    • 5.2 China Nuclear Medicine/Radiopharmaceuticals Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 6.1 North China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 North China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    7 Central China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 7.1 Central China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 Central China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    8 South China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 8.1 South China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 South China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    9 East China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 9.1 East China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 East China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    10 Northeast China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 10.1 Northeast China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Northeast China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    11 Southwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 11.1 Southwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 11.2 Southwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    12 Northwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 12.1 Northwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 12.2 Northwest China Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Dongcheng

      • 13.1.1 Dongcheng Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Advanced Molecular-imaging Solution

      • 13.2.1 Advanced Molecular-imaging Solution Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Shanghai Atom Kexing

      • 13.3.1 Shanghai Atom Kexing Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 China Isotope & Radiation

      • 13.4.1 China Isotope & Radiation Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Ciaeriar

      • 13.5.1 Ciaeriar Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Jaco

      • 13.6.1 Jaco Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Diagnostic from 2016 to 2027

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2016 to 2027

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine/Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Nuclear Medicine/Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine/Radiopharmaceuticals by Different Types from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceuticals by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostic

    • Figure Market Size and Growth Rate of Therapeutic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Nuclear Medicine/Radiopharmaceuticals by Different End-Users from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceuticals by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Thyroid

    • Figure Market Size and Growth Rate of Cardiology

    • Table China Nuclear Medicine/Radiopharmaceuticals Production by Regions

    • Table China Nuclear Medicine/Radiopharmaceuticals Production Share by Regions

    • Figure China Nuclear Medicine/Radiopharmaceuticals Production Share by Regions in 2016

    • Figure China Nuclear Medicine/Radiopharmaceuticals Production Share by Regions in 2021

    • Figure China Nuclear Medicine/Radiopharmaceuticals Production Share by Regions in 2027

    • Table China Nuclear Medicine/Radiopharmaceuticals Consumption by Regions

    • Table China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Regions

    • Figure China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Regions in 2016

    • Figure China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Regions in 2021

    • Figure China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Regions in 2027

    • Table North China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table North China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure North China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Central China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Central China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Central China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table South China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table South China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure South China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table East China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table East China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure East China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Northeast China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Southwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Northwest China Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Advanced Molecular-imaging Solution

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Molecular-imaging Solution

    • Figure Sales and Growth Rate Analysis of Advanced Molecular-imaging Solution

    • Figure Revenue and Market Share Analysis of Advanced Molecular-imaging Solution

    • Table Product and Service Introduction of Advanced Molecular-imaging Solution

    • Table Company Profile and Development Status of Shanghai Atom Kexing

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Atom Kexing

    • Figure Sales and Growth Rate Analysis of Shanghai Atom Kexing

    • Figure Revenue and Market Share Analysis of Shanghai Atom Kexing

    • Table Product and Service Introduction of Shanghai Atom Kexing

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Ciaeriar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ciaeriar

    • Figure Sales and Growth Rate Analysis of Ciaeriar

    • Figure Revenue and Market Share Analysis of Ciaeriar

    • Table Product and Service Introduction of Ciaeriar

    • Table Company Profile and Development Status of Jaco

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jaco

    • Figure Sales and Growth Rate Analysis of Jaco

    • Figure Revenue and Market Share Analysis of Jaco

    • Table Product and Service Introduction of Jaco


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.